268 related articles for article (PubMed ID: 28264157)
1. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Hartman KA; Sherman MB; De Rosa E; Kirui DK; Salvatore F; Tasciotti E
ACS Nano; 2017 Mar; 11(3):3262-3273. PubMed ID: 28264157
[TBL] [Abstract][Full Text] [Related]
2. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
[TBL] [Abstract][Full Text] [Related]
3. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
Pustulka SM; Ling K; Pish SL; Champion JA
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
[TBL] [Abstract][Full Text] [Related]
4. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
5. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
6. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
Yang K; Mesquita B; Horvatovich P; Salvati A
Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
[TBL] [Abstract][Full Text] [Related]
7. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
[TBL] [Abstract][Full Text] [Related]
8. Liposome protein corona characterization as a new approach in nanomedicine.
Capriotti AL; Cavaliere C; Piovesana S
Anal Bioanal Chem; 2019 Jul; 411(19):4313-4326. PubMed ID: 30758528
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers.
Berrecoso G; Crecente-Campo J; Alonso MJ
Drug Deliv Transl Res; 2020 Jun; 10(3):730-750. PubMed ID: 32152965
[TBL] [Abstract][Full Text] [Related]
10. In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.
Kari OK; Ndika J; Parkkila P; Louna A; Lajunen T; Puustinen A; Viitala T; Alenius H; Urtti A
Nanoscale; 2020 Jan; 12(3):1728-1741. PubMed ID: 31894806
[TBL] [Abstract][Full Text] [Related]
11. Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona.
Weber C; Voigt M; Simon J; Danner AK; Frey H; Mailänder V; Helm M; Morsbach S; Landfester K
Biomacromolecules; 2019 Aug; 20(8):2989-2999. PubMed ID: 31268685
[TBL] [Abstract][Full Text] [Related]
12. The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.
Hadjidemetriou M; McAdam S; Garner G; Thackeray C; Knight D; Smith D; Al-Ahmady Z; Mazza M; Rogan J; Clamp A; Kostarelos K
Adv Mater; 2019 Jan; 31(4):e1803335. PubMed ID: 30488990
[TBL] [Abstract][Full Text] [Related]
13. Biological effects of formation of protein corona onto nanoparticles.
Mishra RK; Ahmad A; Vyawahare A; Alam P; Khan TH; Khan R
Int J Biol Macromol; 2021 Apr; 175():1-18. PubMed ID: 33508360
[TBL] [Abstract][Full Text] [Related]
14. Amphiphilic dendrimers control protein binding and corona formation on liposome nanocarriers.
Wagner J; Dillenburger M; Simon J; Oberländer J; Landfester K; Mailänder V; Ng DYW; Müllen K; Weil T
Chem Commun (Camb); 2020 Aug; 56(61):8663-8666. PubMed ID: 32608398
[TBL] [Abstract][Full Text] [Related]
15. Interplay of protein corona and immune cells controls blood residency of liposomes.
Giulimondi F; Digiacomo L; Pozzi D; Palchetti S; Vulpis E; Capriotti AL; Chiozzi RZ; Laganà A; Amenitsch H; Masuelli L; Peruzzi G; Mahmoudi M; Screpanti I; Zingoni A; Caracciolo G
Nat Commun; 2019 Aug; 10(1):3686. PubMed ID: 31417080
[TBL] [Abstract][Full Text] [Related]
16. Differential cellular responses to FDA-approved nanomedicines: an exploration of albumin-based nanocarriers and liposomes in protein corona formation.
Putri AD; Hsu MJ; Han CL; Chao FC; Hsu CH; Lorenz CD; Hsieh CM
Nanoscale; 2023 Nov; 15(44):17825-17838. PubMed ID: 37850423
[TBL] [Abstract][Full Text] [Related]
17. In Situ Characterization of Protein Corona Formation on Silica Microparticles Using Confocal Laser Scanning Microscopy Combined with Microfluidics.
Weiss ACG; Krüger K; Besford QA; Schlenk M; Kempe K; Förster S; Caruso F
ACS Appl Mater Interfaces; 2019 Jan; 11(2):2459-2469. PubMed ID: 30600987
[TBL] [Abstract][Full Text] [Related]
18. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
19. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
Cai R; Chen C
Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
[TBL] [Abstract][Full Text] [Related]
20. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.
Weber C; Simon J; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
